We studied the mechanisms of hypolipidemic effects of NIP-200 iphenyl-
tetrahydro-2H-1,3,5-thiadiazine-2-thione), a potent hypolipidemic comp
ound, in cholesterol biosynthesis in the liver, cholesterol absorption
in small intestine, and cholesterol catabolism and excretion in rats.
NIP-200 did not reduce cholesterol biosynthesis and had no effects on
cholesterol absorption in the small intestine. In the cholesterol cat
abolism and excretion, NIP-200 induced increases in cholesterol and bi
le acids levels in the bile and acidic steroids in the feces, and it e
nhanced cholesterol 7alpha-hydroxylase activity in the liver. These re
sults suggest that NIP-200 increases the synthesis of bile acids as a
result of the activation of cholesterol 7alpha-hydroxylase, the rate-l
imiting enzyme in the conversion of cholesterol to bile acids. Therefo
re, it is considered that one of the probable mechanisms of the serum
total cholesterol lowering action of NIP-200 involves the enhancement
of catabolism and excretion of cholesterol in the liver.